CorVel Launches Pharmacy Technician Certification (CPhT) Test Preparation Program
12 Abril 2023 - 8:14AM
CorVel Corporation (NASDAQ: CRVL), a national provider of risk
management solutions, has developed a pharmacy technician
certification (CPhT) test preparation program to expand the
availability of pharmacy training and increase team certifications.
CorVel requires all employees participating in pharmacy benefit
management to be trained and certified as pharmacy technicians,
setting a new standard of knowledge in workers' compensation.
The initiative began during the pandemic when access to the
usual education channels changed. CorVel developed an internal test
preparation program for team members meeting the 50 hours of
pharmacy experience required to obtain their pharmacy tech
certification. The program consists of an eight-week course to
prepare team members for the certification exam. Among the most
recent training group, 100 percent passed the exam to obtain
certification.
"Those handling the oversight of prescription medications have
always been certified pharmacy technicians. What makes CorVel’s
program unique is that we believe it is important for all team
members involved, not just those on the frontline, to have this
knowledge," said Sarah Scott, CorVel's Vice President of Network
Services. "This includes individuals performing formulary support,
report analysts and evaluators, and personnel tracking state
regulatory changes. With a shared foundation of this pharmacy
knowledge, we are raising the standard of oversight,
problem-solving, and risk management for all our customers."
CorVel's approach to pharmacy benefit management uses a
"high-touch" model, engaging resources at the point of sale when an
injured worker goes to the pharmacy to fill a prescription.
Connection with a pharmacy tech at the point of sale makes it
possible to ensure the prescription is safe, work-related, and
cost-effective for our customers.
CorVel's pharmacy team also closely monitors the use of
dangerously addictive drugs such as opioids, using morphine
equivalency scores to identify potential problems and intervening
directly with the patient's physician to find alternatives. A close
partnership between case managers, adjusters, and pharmacy staff
leads to a faster, safer recovery for each patient.
For more information about CorVel's pharmacy benefit management
program, click here.
About CorVel
CorVel Corp. applies technology, including artificial
intelligence, machine learning and natural language processing to
enhance the managing of episodes of care and the related health
care costs. We partner with employers, third-party
administrators, insurance companies and government agencies in
managing worker’s compensation and health, auto and liability
services. Our diverse suite of solutions combines our integrated
technologies with a human touch. CorVel's customized services,
delivered locally, are backed by a national
team to support our partners as well as their
customers and patients.
Safe Harbor Statement under the Private Securities
Litigation Reform Act of 1995
All statements included in this press release, other than
statements or characterizations of historical fact, are
forward-looking statements. These forward-looking statements are
based on the Company’s current expectations, estimates and
projections about the Company, management’s beliefs, and certain
assumptions made by the Company, and events beyond the Company’s
control, all of which are subject to change. Such forward-looking
statements include, but are not limited to, statements relating to
the Company’s pharmacy services and the Company’s continued
investment in these and other innovative technologies, and
statements relating to the Company’s workers’ comp service
offerings. These forward-looking statements are not guarantees of
future results and are subject to risks, uncertainties and
assumptions that could cause the Company’s actual results to differ
materially and adversely from those expressed in any
forward-looking statement, including the risk that the impact of
the COVID-19 pandemic on our business, results of operations and
financial condition is greater than our initial assessment.
The risks and uncertainties referred to above include but are
not limited to factors described in this press release and the
Company’s filings with the Securities and Exchange Commission,
including but not limited to “Risk Factors” in the Company’s Annual
Report on Form 10-K for the year ended March 31, 2022 and the
Company’s Quarterly Report on Form 10-Q for the quarters ended June
30, 2022 and September 30, 2022. The forward-looking statements in
this press release speak only as of the date they are made. The
Company undertakes no obligation to revise or update publicly any
forward-looking statement for any reason.
CorVel Corporation |
801 Cherry St. #2400 |
Fort Worth, TX 76102 |
|
Contact: Melissa Storan |
Phone: 949-851-1473 |
www.corvel.com |
CorVel (NASDAQ:CRVL)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024
CorVel (NASDAQ:CRVL)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024